Oleik Aside Bağlı Akut Akciğer Hasarı Modeli Oluşturulan Ratlarda Tocilizumab ve Deksametazon'un Karaciğer Üzerine Etkilerinin Histopatolojik Olarak İncelenmesi

Amaç: Bu çalışmada, oleik asit ile akut akciğer hasarı modeli oluşturulan ratlarda Tocilizumab ve Deksametazon'un karaciğer üzerindeki etkilerinin incelenmesi hedeflenmiştir. Gereç ve Yöntem: Çalışma materyalini otuz altı erkek rat oluşturdu ve CN, OA, TCZ ve DEX olmak üzere altı gruba ayrıldı. Kontrol grubu dışındaki tüm gruplar intravenöz olarak OA verildi. OA enjeksiyonlarından sonra diğer bileşikler intravenöz olarak uygulandı (DEX 0.1 mg/kg ve DEX 10 mg/kg, TCZ 2 mg/kg ve TCZ 4 mg/kg). Bulgular: OA+DEX 10 grubu sıçanlarda hepatositlerde hidropik dejenerasyonun diğer gruplara göre arttığı belirlendi (p

Histopathological Examination of the Effects of Tocilizumab and Dexamethasone on the Liver in Rats of Oleic Acid induced Acute Lung Injury

Objective: This study, it was aimed to examine the effects of Tocilizumab and Dexamethasone on the liver in rats in which the acute lung injury model was created with Oleic acid. Materials and Methods: Thirty-six male rats were used as study material and were divided into six groups as Control, OA, TCZ and DEX. All groups except the control group received OA intravenously and after OA injections other compounds were administered intravenously (DEX 0.1 mg/kg and DEX 10 mg/kg, TCZ 2 mg/kg and TCZ 4 mg/kg). Results: It was determined that hydropic degeneration increased in hepatocytes in OA+ DEX 10 group rats compared to other groups (p

PDF

___

Abdelhalim, M. A. K., & Jarrar, B. M. (2011). Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids in Health and Disease, 10(1), 1-6. https://doi.org/10.1186/1476-511x-10-166
Akella, A., Sharma, P., Pandey, R., & Deshpande, S. B. (2014). Characterization of oleic acid-induced acute respiratory distress syndrome model in rat. Indian Journal of Experimental Biology, 52(7):712-9. https://doi.org/10.1016/j.toxicon.2015.02.004
Beilman, G. (1995). Pathogenesis of oleic acid-induced lung injury in the rat: distribution of oleic acid during injury and early endothelial cell changes. Lipids, 30(9), 817-823. https://doi.org/10.1007/bf02533957
Bleibel, W., Kim, S., D’Silva, K., & Lemmer, E. R. (2007). Drug-induced liver injury. Digestive Diseases and Sciences, 52(10), 2463-2471. https://doi.org/10.1007/s10620-006-9472-y
Browning, J. D., & Horton, J. D. (2004). Molecular mediators of hepatic steatosis and liver injury. The Journal of clinical investigation, 114(2), 147-152. https://doi.org/10.1172/jci200422422
Bulmuş, F. G., Gürsu, M. F., Muz, M. H., Yaman, İ., Bulmuş, Ö., & Sakin, F. (2013). Protective effects of alpha- lipoic acid on oleic acid-induced acute lung injury in rats. Balkan medical journal, 30(3), 309. https://doi.org/10.5152/balkanmedj.2013.8426
Canbay, A., Gieseler, R., Gores, G., & Gerken, G. (2005). The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. Zeitschrift für Gastroenterologie, 43(02), 211-217. https://doi.org/10.1055/s-2004-813744
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., & Woo, P. (2012). Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. New England Journal of Medicine, 367(25), 2385-2395. https://doi.org/10.1056/nejmoa1112802
Drucker, C., Gewiese, J., Malchow, S., Scheller, J., & Rose- John, S. (2010). Impact of interleukin-6 classic-and trans-signaling on liver damage and regeneration. Journal of Autoimmunity, 34(1), 29-37. https://doi.org/10.1016/j.jaut.2009.08.003
Ducheix, S., Montagner, A., Polizzi, A., Lasserre, F., Regnier, M., Marmugi, A., Benhamed, F., Bertrand-Michel, J., Mselli-Lakhal, L., & Loiseau, N. (2017). Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling. PLoS One, 12(7), e0181393. https://doi.org/10.1371/journal.pone.0181393
Erol, N., Saglam, L., Saglam, Y. S., Erol, H. S., Altun, S., Aktas, M. S., & Halici, M. B. (2019). The protection potential of antioxidant vitamins against acute respiratory distress syndrome: a rat trial. Inflammation, 42(5), 1585-1594. https://doi.org/10.1007/s10753-019-01020-2
Herrero, R., Sánchez, G., Asensio, I., López, E., Ferruelo, A., Vaquero, J., Moreno, L., de Lorenzo, A., Bañares, R., & Lorente, J. A. (2020). Liver–lung interactions in acute respiratory distress syndrome. Intensive Care Medicine Experimental, 8(1), 1-13. https://doi.org/10.1186/s40635-020-00337-9
Kang, O., Kim, S., Seo, Y., Joung, D., Mun, S., Choi, J., Lee, Y., Kang, D., Lee, H., & Kwon, D. (2013). Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells. European Review for Medical and Pharmacological Sciences, 17(19), 2578-2586. https://doi.org/10.1039/d0fo00594k
Kleiner, D. E. (2009). The pathology of drug-induced liver injury. (Ed.),^(Eds.). Seminars in liver disease. https://doi.org/10.1055/s-0029-1240005
Koh, Y. (2014). Update in acute respiratory distress syndrome. Journal of Intensive Care, 2(1), 1-6. https://doi.org/10.1186/2052-0492-2-2
Koksel, O., Kaplan, M. B., Ozdulger, A., Tamer, L., Degirmenci, U., Cinel, L., Bastürk, M., & Kanik, A. (2005). Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Experimental Lung Research, 31(5), 483-496. https://doi.org/10.1080/01902140590918876
Lee, J. Y., Moon, J. H., Park, J. S., Lee, B.-W., Kang, E. S., Ahn, C. W., Lee, H. C., & Cha, B. S. (2011). Dietary oleate has beneficial effects on every step of non- alcoholic Fatty liver disease progression in a methionine-and choline-deficient diet-fed animal model. Diabetes & Metabolism Journal, 35(5), 489. https://doi.org/10.4093/dmj.2011.35.5.489
Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020). Tocilizumab treatment in COVID 19: a single center experience. Journal of Medical Virology, 92(7), 814- 818. https://doi.org/10.1002/jmv.25801
Mahamid, M., Paz, K., Reuven, M., & Safadi, R. (2011). Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports. International Journal of General Medicine, 4, 657. https://doi.org/10.2147/ijgm.s23920
Matute-Bello, G., Frevert, C. W., & Martin, T. R. (2008). Animal models of acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology, 295(3), L379-L399. https://doi.org/10.1152/ajplung.00010.2008
Mikiewicz, M., Otrocka-Domagała, I., Paździor-Czapula, K., & Rotkiewicz, T. (2017). Influence of long-term, high- dose dexamethasone administration on proliferation and apoptosis in porcine hepatocytes. Research in Veterinary Science, 112, 141-148. https://doi.org/10.1016/j.rvsc.2017.03.018
Moore, B. B., & Hogaboam, C. M. (2008). Murine models of pulmonary fibrosis. American Journal of Physiology- Lung Cellular and Molecular Physiology, 294(2), L152-L160. https://doi.org/10.1152/ajplung.00313.2007
Muhović, D., Bojović, J., Bulatović, A., Vukčević, B., Ratković, M., Lazović, R., & Smolović, B. (2020). First case of drug induced liver injury associated with the use of tocilizumab in a patient with COVID 19. Liver International, 40(8), 1901-1905. https://doi.org/10.1111/liv.14516
Okun, J. G., Conway, S., Schmidt, K. V., Schumacher, J., Wang, X., de Guia, R., Zota, A., Klement, J., Seibert, O., & Peters, A. (2015). Molecular regulation of urea cycle function by the liver glucocorticoid receptor. Molecular Metabolism, 4(10), 732-740. https://doi.org/10.1016/j.molmet.2015.07.006
Oldfield, V., Dhillon, S., & Plosker, G. L. (2009). Tocilizumab. Drugs, 69(5), 609-632. https://doi.org/10.2165/00003495-200969050-00007
Pascussi, J. M., Drocourt, L., Gerbal Chaloin, S., Fabre, J. M., Maurel, P., & Vilarem, M. J. (2001). Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes: sequential role of glucocorticoid receptor and pregnane X receptor. European Journal of Biochemistry, 268(24), 6346-6358. https://doi.org/10.1046/j.0014-2956.2001.02540.x
Patel, R., Patel, M., Tsai, R., Lin, V., Bookout, A. L., Zhang, Y., Magomedova, L., Li, T., Chan, J. F., & Budd, C. (2011). LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. The Journal of Clinical Investigation, 121(1), 431-441. https://doi.org/10.1172/jci41681
Patterson, E., Yao, L., Ramic, N., Lewis, J., Cepinskas, G., McCaig, L., Veldhuizen, R., & Yamashita, C. (2013). Lung-derived mediators induce cytokine production in downstream organs via an NF-κB-dependent mechanism. Mediators of Inflammation, 2013. https://doi.org/10.1155/2013/586895
Roussel, D., Dumas, J.-F., Simard, G., Malthièry, Y., & Ritz, P. (2004). Kinetics and control of oxidative phosphorylation in rat liver mitochondria after dexamethasone treatment. Biochemical Journal, 382(2), 491-499. https://doi.org/10.1042/bj20040696
Schuster, D. P. (1994). ARDS: clinical lessons from the oleic acid model of acute lung injury. American Journal of Respiratory and Critical Care Medicine, 149(1), 245- 260. https://doi.org/10.1164/ajrccm.149.1.8111590
Schwartz, D. B., Bone, R. C., Balk, R. A., & Szidon, J. R. (1989). Hepatic dysfunction in the adult respiratory distress syndrome. Chest, 95(4), 871-875. https://doi.org/10.1378/chest.95.4.871
Serviddio, G., Villani, R., Stallone, G., Scioscia, G., Foschino- Barbaro, M. P., & Lacedonia, D. (2020). Tocilizumab and liver injury in patients with COVID-19. Therapeutic Advances in Gastroenterology, 13, 1756284820959183. https://doi.org/10.1177/1756284820959183
Slutsky, A. S., & Ranieri, V. M. (2013). Ventilator-induced lung injury. New England Journal of Medicine, 369(22), 2126-2136. https://doi.org/10.1056/nejmra1208707
Sukharomana, M., Udomittipong, K., Ruangchira-Urai, R., & Charuvanij, S. (2019). Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-050819-0616
Sun, S., Liu, D., Zhang, H., Zhang, X., & Wan, B. (2019). Effect of different doses and time-courses of corticosteroid treatment in patients with acute respiratory distress syndrome: A meta-analysis. Experimental and Therapeutic Medicine, 18(6), 4637-4644.
Tanaka, T., Ogata, A., & Narazaki, M. (2010). Tocilizumab for the treatment of rheumatoid arthritis. Expert Review of Clinical İmmunology, 6(6), 843-854.
Wan, E. S., Qiu, W., Baccarelli, A., Carey, V. J., Bacherman, H., Rennard, S. I., Agustí, A., Anderson, W. H., Lomas, D. A., & DeMeo, D. L. (2012). Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 186(12), 1248-1255.
Wiener-Kronish, J., Albertine, K., & Matthay, M. (1991). Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. The Journal of Clinical İnvestigation, 88(3), 864-875.
Yang, P., Formanek, P., Scaglione, S., & Afshar, M. (2019). Risk factors and outcomes of acute respiratory distress syndrome in critically ill patients with cirrhosis. Hepatology Research, 49(3), 335-343.
Ziamajidi, N., Khaghani, S., Hassanzadeh, G., Vardasbi, S., Ahmadian, S., Nowrouzi, A., Ghaffari, S. M., & Abdirad, A. (2013). Amelioration by chicory seed extract of diabetes-and oleic acid-induced non- alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food and Chemical Toxicology, 58, 198-209.